SELOXIUM JOINS GROWING SCIENCE COMMUNITY AT ARC OXFORD
We are excited to announce that Seloxium Ltd., a University of Oxford Spin-out company, has taken over 2,000 sq. ft of laboratory and office space at ARC Oxford, further strengthening the ever-growing community of science and technology organisations on the campus.
Seloxium has developed new patented technology to change the way valuable metals are mined, refined, processed and recycled, offering a more sustainable and environmentally friendly source of the green metals which are vital to meeting global climate goals.
Seloxium will join over 20 science and tech organisations at ARC Oxford including; Oxford Biomedica (who manufactured the AstraZeneca covid vaccine), MiroBio (who are developing antibody drugs for autoimmune disorders), and Ivy Farm (who are leading the UK’s cultivated meat revolution), as well as law firm Pennington Manches Cooper, who provide legal advice to scientific, pharmaceutical and biotechnology clients.
David Williams, senior director of leasing at ARC, said: “We’re delighted to welcome Seloxium to our community of world-changing companies. We’re working closely with Seloxium during the fit-out process to ensure their overall space and laboratories are designed and built to help support the company to grow as they develop more sustainable sources for green metals.”
Dr Christian Peters, CEO Seloxium Ltd. Said: “We are delighted to be joining the community of cutting-edge scientific companies based at ARC. The team at Seloxium looks forward to being part of the successful and thriving community of innovative companies making the world a greener and more sustainable place.”